Manganese Bone Density Randomized Trial: What the Evidence Says

Quick Answer

Manganese Bone Density Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Dysregulation manifests as lipid abnormalities in obesity, insulin resistance associated with type 2 diabetes mellitus (T2DM), hepatic steatosis, and chronic low-grade inflammation, all of which have a multifaceted impact on bone homeostasis. [Basak Sanjay (2026); evidence level 3]
• Recent evidence has highlighted the coexistence of obesity or T2DM with various bone disorders. [Basak Sanjay (2026); evidence level 3]
• However, due to the limited number of human studies investigating the effects of vitamin D supplementation on implant outcomes, the current evidence remains weak and preliminary. [Sodnom-Ish Buyanbileg (2026); evidence level 4]
• Despite the recent growing interest and research insights, there is limited evidence on how the deficiency or supplementation of other micronutrients (e.g., boron, selenium, copper, or iron) influences osseointegration or the long-term implant survival and success. [Sodnom-Ish Buyanbileg (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For manganese bone density randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Basak Sanjay (2026). Roles of gut metabolites on bone mineralization and remodeling: impact of metabolic dysregulation on the gut-immune-bone axis. DOI: 10.3389/fendo.2026.1774824. PMCID: PMC13160868. PMID: 42130740. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13160868/
• Sodnom-Ish Buyanbileg (2026). The effect of dietary factors and nutrients on osseointegration, dental implant success and survival: a scoping review. DOI: 10.1186/s40729-026-00680-8. PMCID: PMC13187093. PMID: 41936654. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13187093/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.